Indivior Pharmaceuticals, Inc. — 6-K Filings
337 6-K filings on record
This page lists all 6-K filings submitted to the SEC by Indivior Pharmaceuticals, Inc. (INDV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Indivior Pharmaceuticals, Inc. has filed 337 6-K documents with the SEC since 2014. To view all SEC filings by Indivior Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
15-12G
20-F
20FR12B
20FR12B/A
3
4
6-K
6-K/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
F-6
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | TOTAL VOTING RIGHTS | 0001654954-25-002190 | Mar 3, 2025 | — |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | 0001654954-25-002094 | Feb 28, 2025 | — |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | 0001654954-25-002097 | Feb 28, 2025 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-25-002084 | Feb 28, 2025 | — |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | 0001654954-25-002009 | Feb 27, 2025 | — |
| 6-K | JOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICER | 0001654954-25-001997 | Feb 27, 2025 | — |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | 0001654954-25-002012 | Feb 27, 2025 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-25-001875 | Feb 25, 2025 | — |
| 6-K | FDA APPROVAL OF SUBLOCADE LABEL CHANGES | 0001654954-25-001833 | Feb 24, 2025 | — |
| 6-K | 6-K | 0001625297-25-000003 | Feb 20, 2025 | Dec 31, 2024 |
| 6-K | DELAYED FDA APPROVAL OF SUBLOCADE LABEL CHANGES | 0001654954-25-001381 | Feb 12, 2025 | — |
| 6-K | COMPLETION OF SHARE REPURCHASE PROGRAM | 0001654954-25-001126 | Feb 4, 2025 | — |
| 6-K | NOTICE OF RESULTS | 0001654954-25-001135 | Feb 4, 2025 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-25-001124 | Feb 4, 2025 | — |
| 6-K | APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | 0001654954-25-001033 | Feb 3, 2025 | — |
| 6-K | TOTAL VOTING RIGHTS | 0001654954-25-001036 | Feb 3, 2025 | — |
| 6-K | DR. DAVID WHEADON APPOINTED CHAIR OF THE BOARD | 0001654954-25-000867 | Jan 28, 2025 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-25-000851 | Jan 28, 2025 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-25-000849 | Jan 28, 2025 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-25-000775 | Jan 27, 2025 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-25-000585 | Jan 21, 2025 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-25-000321 | Jan 14, 2025 | — |
| 6-K | INDIVIOR PROVIDES HISTORICAL FINANCIALS IN US GAAP | 0001654954-25-000203 | Jan 10, 2025 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-25-000156 | Jan 7, 2025 | Jan 7, 2024 |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-25-000158 | Jan 7, 2025 | Jan 7, 2024 |
| 6-K | TOTAL VOTING RIGHTS | 0001654954-25-000025 | Jan 2, 2025 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-24-015996 | Dec 31, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-015987 | Dec 31, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-015889 | Dec 26, 2024 | — |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | 0001654954-24-015853 | Dec 23, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-015641 | Dec 17, 2024 | — |
| 6-K | INDIVIOR ANNOUNCES CHANGES TO BOARD OF DIRECTORS | 0001654954-24-015644 | Dec 17, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-015335 | Dec 10, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-015121 | Dec 3, 2024 | — |
| 6-K | TOTAL VOTING RIGHTS | 0001654954-24-015047 | Dec 2, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-014894 | Nov 26, 2024 | — |
| 6-K | INDIVIOR TO PARTICIPATE IN UPCOMING INVESTOR EVENT | 0001654954-24-014795 | Nov 22, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-014636 | Nov 19, 2024 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-24-014579 | Nov 18, 2024 | — |
| 6-K | DIRECTOR DECLARATION | 0001654954-24-014512 | Nov 15, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-014080 | Nov 12, 2024 | — |
| 6-K | HOLDING(S) IN COMPANY | 0001654954-24-014065 | Nov 12, 2024 | — |
| 6-K | INDIVIOR RESPONDS TO LETTER FROM OAKTREE | 0001654954-24-013970 | Nov 8, 2024 | — |
| 6-K | BLOCK LISTING INTERIM REVIEW | 0001654954-24-014007 | Nov 8, 2024 | — |
| 6-K | 6-K | 0001193125-24-254125 | Nov 8, 2024 | — |
| 6-K | INDIVIOR COMPLETES REFINANCE OF SECURED TERM LOAN | 0001654954-24-013729 | Nov 5, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-013727 | Nov 5, 2024 | — |
| 6-K | TOTAL VOTING RIGHTS | 0001654954-24-013612 | Nov 1, 2024 | — |
| 6-K | TRANSACTION IN OWN SHARES | 0001654954-24-013422 | Oct 29, 2024 | — |
| 6-K | 6-K | 0001625297-24-000038 | Oct 24, 2024 | Sep 30, 2024 |